Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Austco HealthcareASX:AHC 63 3-1 Month Momentum % is 6.98% as of Sep. 17, 2026. GuruFocus rates ASX:AHC with a GF Score™ of 63/100 and a GF Value™ of A$0.34 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 841 Medical Devices & Instruments companies, Austco Healthcare ranks better than 79.43% on this metric.
3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-17), Austco Healthcare's 3-1 Month Momentum % is 6.98%.
The industry rank for Austco Healthcare's 3-1 Month Momentum % or its related term are showing as below:
ASX:AHC's 3-1 Month Momentum % is ranked better than 79.43% of 841
companies
in the Medical Devices & Instruments industry
Industry Median: 0.95
vs ASX:AHC: 6.98
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Austco Healthcare 3-1 Month Momentum % Related Terms
ASX:AHC vs ISRG, BDX, RMD: 3-1 Month Momentum % Comparison
For the Medical Instruments & Supplies subindustry, Austco Healthcare's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Austco Healthcare 3-1 Month Momentum % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Austco Healthcare's 3-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Austco Healthcare's 3-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Austco Healthcare (ASX:AHC) has a 3-1 Month Momentum % of 6.98% as of Sep. 17, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Austco Healthcare and its competitors. According to the industry distribution chart, Austco Healthcare ranks #173 out of 841 companies in the Medical Devices & Instruments industry, placing it in the top 20.6%.
Is Austco Healthcare's 3-1 Month Momentum % too high?
Austco Healthcare's current 3-1 Month Momentum % is 6.98%. The Medical Devices & Instruments industry median 3-1 Month Momentum % is 0.95. Austco Healthcare's value of 6.98% is 634.7% above this industry median. Based on the distribution chart, Austco Healthcare ranks #173 out of 841 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Austco Healthcare has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Austco Healthcare's 3-1 Month Momentum % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Austco Healthcare ranks #173 out of 841 companies for 3-1 Month Momentum %. This places Austco Healthcare in the top 21% of its industry — outperforming the majority of peers. The industry median 3-1 Month Momentum % is 0.95. Austco Healthcare's value of 6.98% is 634.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Medical Devices & Instruments company?
The median 3-1 Month Momentum % among Medical Devices & Instruments companies is 0.95, based on 841 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Austco Healthcare's current 3-1 Month Momentum % of 6.98% is 634.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on Austco Healthcare and its competitors. For the Medical Devices & Instruments industry, the median 3-1 Month Momentum % is 0.95 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Austco Healthcare's current 3-1 Month Momentum % is 6.98%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Austco Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Austco Healthcare (ASX:AHC) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.34, compared to a current price of A$0.27 — trading 20.6% below its estimated fair value. The current 3-1 Month Momentum % is 6.98% and 634.7% above the Medical Devices & Instruments industry median of 0.95. Austco Healthcare's overall GF Score™ is 63/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For Austco Healthcare (ASX:AHC), the current 3-1 Month Momentum % is 6.98% as of Sep. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Austco Healthcare (ASX:AHC) Overvalued in 2026?
Based on GuruFocus' analysis, Austco Healthcare stock appears to be undervalued.
The current stock price of A$0.27 is trading 20.6% below its estimated GF Value™ of A$0.34.
GuruFocus considers Austco Healthcare to be Modestly Undervalued.
Key valuation signals for ASX:AHC:
3-1 Month Momentum %: 6.98%
GF Value™: A$0.34 vs. price of A$0.27 (20.6% below fair value)
Industry Position: 634.7% above the Medical Devices & Instruments median (#173 of 841)
No single metric tells the full story. See the ASX:AHC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Austco Healthcare Ltd engages in the development and provision of electronic communications and clinical management solutions. It offers Tacera, a nurse call, and healthcare communication system for healthcare professionals and patient. The group is segmented into four geographic regions consisting of Australia/New Zealand, Asia, Europe, and North America.
63GF Score
Get the complete analysis for ASX:AHC
3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AHC has been successfully added to your 
